Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Correction

Correction: TGM2, HMGA2, FXYD3, and LGALS4 genes as biomarkers in acquired oxaliplatin resistance of human colorectal cancer: A systems biology approach

  • Tayebeh Cheraghi-shavi,
  • Razieh Jalal,
  • Zarrin Minuchehr,
  • Frouzandeh Mahjoubi

Frouzandeh Mahjoubi is not included in the author byline. Frouzandeh Mahjoubi should be listed as the fourth author and is affiliated with Department of Medical Genetics, Institute of Medical Biotechnology, National Institute of Genetic Engineering and Biotechnology, Tehran, Iran. The contributions of this author are as follows: Methodology, Supervision.

The correct citation is: Cheraghi-shavi T, Jalal R, Minuchehr Z, Mahjoubi F (2023) TGM2, HMGA2, FXYD3, and LGALS4 genes as biomarkers in acquired oxaliplatin resistance of human colorectal cancer: A systems biology approach. PLoS ONE 18(8): e0289535. https://doi.org/10.1371/journal.pone.0289535.

Reference

  1. 1. Cheraghi-Shavi T, Jalal R, Minuchehr Z. TGM2, HMGA2, FXYD3, and LGALS4 genes as biomarkers in acquired oxaliplatin resistance of human colorectal cancer: a systems biology approach. PLoS One. 2023;18(8): e0289535. pmid:37535601

Citation: Cheraghi-shavi T, Jalal R, Minuchehr Z, Mahjoubi F (2025) Correction: TGM2, HMGA2, FXYD3, and LGALS4 genes as biomarkers in acquired oxaliplatin resistance of human colorectal cancer: A systems biology approach. PLoS ONE 20(4): e0322319. https://doi.org/10.1371/journal.pone.0322319

Published: April 4, 2025

Copyright: © 2025 Cheraghi-shavi et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.